Nimptsch Ulrike, Krautz Christian, Weber Georg F, Mansky Thomas, Grützmann Robert
*Technische Universität Berlin, Department for Structural Advancement and Quality Management in Health Care, Steinplatz 2, Berlin, Germany†Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Chirurgische Klinik, Krankenhausstraße 12, Erlangen, Germany.
Ann Surg. 2016 Dec;264(6):1082-1090. doi: 10.1097/SLA.0000000000001693.
We aimed to determine the unbiased mortality rates for pancreatic surgery procedures at the national level through a comprehensive analysis of every inpatient case in Germany.
Several studies have proclaimed a general improvement of perioperative outcomes following pancreatic surgery. These results are challenged by recent analyses of large US databases that found strong volume-outcome relationships, with high mortality in low-volume facilities.
All inpatient cases with a pancreatic surgery procedure code in Germany from 2009 to 2013 were identified from nationwide administrative hospital data. We determined the absolute number of patients and the in-hospital death rate for crucial subcategories such as medical indications and types of surgical procedure.
A total of 58,003 inpatient episodes of pancreatic surgery were identified between 2009 and 2013. Annual case numbers increased significantly, which was primarily attributed to patients aged 70 years and older. The overall in-hospital mortality rate (10.1%) did not significantly change during the study period. Major pancreatic resections were associated with mortality ranging from 7.3% (distal pancreatectomy) to 22.9% (total pancreatectomy). Postoperative interventions indicative of severe complications were documented frequently (eg, more than 6 blood transfusions in 20% of all patients and relaparotomy in 16%). Their occurrence was associated with a dramatic increase in mortality.
At the national level in Germany, perioperative mortality is higher than anticipated from previous studies. The absence of a significant reduction in overall mortality challenges current health policies that aim to improve the outcomes of high-risk surgical procedures in Germany.
我们旨在通过对德国每一例住院病例进行全面分析,确定全国范围内胰腺手术的无偏倚死亡率。
多项研究宣称胰腺手术后围手术期结局总体有所改善。然而,最近对美国大型数据库的分析对这些结果提出了质疑,这些分析发现手术量与结局之间存在密切关系,低手术量机构的死亡率较高。
从全国性的医院管理数据中识别出2009年至2013年德国所有具有胰腺手术程序编码的住院病例。我们确定了关键亚组(如医学指征和手术类型)的患者绝对数量和院内死亡率。
2009年至2013年期间共识别出58003例胰腺手术住院病例。年度病例数显著增加,这主要归因于70岁及以上的患者。研究期间,总体院内死亡率(10.1%)没有显著变化。主要胰腺切除术的死亡率在7.3%(胰体尾切除术)至22.9%(全胰切除术)之间。经常记录到表明严重并发症的术后干预措施(例如,20%的患者输血超过6次,16%的患者再次剖腹手术)。这些情况的发生与死亡率的急剧上升相关。
在德国全国范围内,围手术期死亡率高于以往研究预期。总体死亡率没有显著降低,这对旨在改善德国高风险手术结局的现行卫生政策提出了挑战。